Y-Intercept (HK)’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Y-Intercept (HK)’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,940	Closed	-$2.65K	–	1453
2022 Q3	$2.65K	Buy	+10,940	New	+$3.97K	﹤0.01%	927

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Y-Intercept (HK)'s SCPS Position: Q4 2022 in Review

Y-Intercept (HK) sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 10,940 shares — an estimated $2.65K sold.

Y-Intercept (HK) first reported a position in SCPS in Q3 2022 and held it in 1 quarter. The position peaked at $2.65K in Q3 2022. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Y-Intercept (HK) reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Y-Intercept (HK) sold 10,940 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $2.65K.
Y-Intercept (HK) first reported a position in Scopus BioPharma Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Scopus BioPharma Inc. Common Stock position peaked at $2.65K in Q3 2022.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Y-Intercept (HK)'s 13F filing for Q4 2022, filed 14 Feb 2023.